U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H21N2O3.Na
Molecular Weight 348.3714
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUMADIZONE SODIUM

SMILES

[Na+].CCCCC(C([O-])=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=JSKMFBFCHQMLJR-UHFFFAOYSA-M
InChI=1S/C19H22N2O3.Na/c1-2-3-14-17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15;/h4-13,17,20H,2-3,14H2,1H3,(H,23,24);/q;+1/p-1

HIDE SMILES / InChI
Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C19H21N2O3
Molecular Weight 325.3816
Charge -1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Bumadizone is a non-steroidal anti-inflammatory drug exerting analgesic, antipyretic and anti-inflammatory properties. It has been studied in the treatment of rheumatoid diseases.

Approval Year

Unknown
149124
Patents

Patents

JP2003528044A
30

Sample Use Guides

In Vivo Use Guide
110 mg twice daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:03:43 GMT 2025
Edited
by admin
on Mon Mar 31 21:03:43 GMT 2025
Record UNII
PP47GRI92P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-BUTYL-N,N'-DIPHENYLMALONOMONOHYDRAZIDE SODIUM SALT
Preferred Name English
BUMADIZONE SODIUM
Common Name English
PROPANEDIOIC ACID, 2-BUTYL-, 1-(1,2-DIPHENYLHYDRAZIDE), SODIUM SALT (1:1)
Systematic Name English
MALONIC ACID, BUTYL-, MONO(1,2-DIPHENYLHYDRAZIDE), MONOSODIUM SALT
Systematic Name English
PROPANEDIOIC ACID, BUTYL-, MONO(1,2-DIPHENYLHYDRAZIDE), MONOSODIUM SALT
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID40932376
Created by admin on Mon Mar 31 21:03:43 GMT 2025 , Edited by admin on Mon Mar 31 21:03:43 GMT 2025
PRIMARY
CAS
14467-30-2
Created by admin on Mon Mar 31 21:03:43 GMT 2025 , Edited by admin on Mon Mar 31 21:03:43 GMT 2025
PRIMARY
FDA UNII
PP47GRI92P
Created by admin on Mon Mar 31 21:03:43 GMT 2025 , Edited by admin on Mon Mar 31 21:03:43 GMT 2025
PRIMARY
PUBCHEM
23675792
Created by admin on Mon Mar 31 21:03:43 GMT 2025 , Edited by admin on Mon Mar 31 21:03:43 GMT 2025
PRIMARY
Related Record Type Details
Structure of BUMADIZONE SODIUM, (S)-
ENANTIOMER -> RACEMATE
Structure of BUMADIZONE SODIUM, (R)-
ENANTIOMER -> RACEMATE
Structure of BUMADIZONE
PARENT -> SALT/SOLVATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966